The span of mortality rate is significantly smaller (about
6-19 in 100.000), due to breast cancer survivals in developed regions (high
incidence). As a result, breast cancer is the fifth cause of deaths in the
total number of deaths (458 000 deaths), and in spite of that, it is still the
leading cause of death in women from all types of cancer locations, and in
countries in development (269 000 deaths, 12.7% of overall mortality) and
developed regions, with an estimated number of 189 000 deaths, which is almost
equal to the estimated number of deaths by lung cancer (188 000 deaths).
Breast
cancer was the leading cancer with women in Bosnia and Herzegovina in the
year 2008, with an incidence 1100 (25.9%) with the standardized world rate ASR
(W) on 100 000 inhabitants, 36.5 and mortality 399 (17%) with the standardized
world rate ASR (W) 22.7.
Breast cancer as a disease effects on financial expenses and
presents an economic burden for reasons that, next to the direct costs, come
the costs of treatment and mortality rates. During a longer period, the
expenses grow according to a similar rate for total health costs. According to
the American National Institute for Health, it is estimated that breast cancer
will cost 209.9 billion dollars in the year 2005, 118.4 billion of which due to
mortality expenses (loss of productivity due to patient's death), 74 billion
due to direct medical expenses (money spent on medical care), which used to be
17.5 billion dollars due to morbidity expenses (costs of loss of productivity
due to disease.
Robert Cummins is the founder of international group of
scientist and researchers (International Well-Being Group), which advocates the
understanding that life
quality is a multi-dimensional construct made from: life standard, health,
productivity, the ability to make close connections, security, the sense of
belonging to a community, and the sense of security in the future.
No comments:
Post a Comment